Q2 2026 13F · SEC CIK 1774437
Your Advocates Ltd., LLP
Wealth managerFiled 2026-08-05 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $349.9M
- Reported positions
- 209
- Top holdings a year, 3 yrs
- +14.8%
- Assets under management
- $448.1M
Your Advocates Ltd., LLP is a wealth manager that reported 209 positions worth $349.9M in its Q2 2026 13F, filed 2026-08-05. Its largest holdings were Dimensional US Core Equity 1 ETF (DCOR, 24.6%), Dimensional ETF Trust (DFIC, 13.1%), Dimensional ETF Trust (DFEM, 9.7%). A portfolio copying its top holdings returned 14.8% a year over the last 3 years, against 20.4% for the S&P 500.
Your Advocates Ltd., LLP holdings largest 50 of 209 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Your Advocates Ltd., LLP bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- VT Vanguard Intl Equity Index F+23.5% shares
- AHLT American Beacon Select Funds+22.0% shares
- SPTS Spdr Series Trust+15.4% shares
- IEFA Ishares Tr+5.9% shares
- SCHR Schwab Strategic Tr+5.6% shares
- BSV Vanguard Bd Index Fds+5.6% shares
Reduced
- BOND Pimco ETF Tr-45.4% shares
- MPC Marathon Petroleum-32.6% shares
- TSLA Tesla Inc-12.5% shares
- SPY State Str Spdr S&p 500 ETF T-9.3% shares
- COP Conocophillips-8.4% shares
- VOO Vanguard Index Fds-6.4% shares
- SCHB Schwab Strategic Tr-5.4% shares
Left the top 50
- MNPR Monopar Therapeutics Incwas 0.1%
- IVE Ishares Trwas 0.0%
- IVW Ishares Trwas 0.0%
- FTI Technipfmc PLCwas 0.0%
- SPTI Spdr Series Trustwas 0.0%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +20.0% /yr
- S&P 500 +20.1%
- 3 years
- +14.8% /yr
- S&P 500 +20.4%
- 5 years
- +6.8% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $349.9M | 209 |
| Q1 2026 | $327.9M | 232 |
| Q4 2025 | $306.4M | 239 |
| Q3 2025 | $298.4M | 220 |
| Q2 2025 | $278.2M | 202 |
| Q1 2025 | $260.6M | 211 |
| Q4 2024 | $251.6M | 209 |
| Q3 2024 | $254.5M | 232 |
| Q2 2024 | $238.2M | 240 |
| Q1 2024 | $236.9M | 235 |
| Q4 2023 | $248.5M | 235 |
| Q3 2023 | $167.6M | 299 |
Questions about Your Advocates Ltd., LLP's portfolio
What stocks does Your Advocates Ltd., LLP own?
Your Advocates Ltd., LLP's latest 13F, for Q2 2026 and filed Aug 5, 2026, lists 209 positions worth $349.9M. The largest are Dimensional US Core Equity 1 ETF (DCOR) at 24.6%, Dimensional ETF Trust (DFIC) at 13.1%, Dimensional ETF Trust (DFEM) at 9.7%, Dimensional ETF Trust (DFAS) at 8.2% and Schwab Strategic Tr (SCHR) at 7.5%.
What did Your Advocates Ltd., LLP buy last quarter?
In Q2 2026, Your Advocates Ltd., LLP added Vanguard Intl Equity Index F (VT) (+23.5% shares), American Beacon Select Funds (AHLT) (+22.0% shares) and Spdr Series Trust (SPTS) (+15.4% shares), compared with its Q1 2026 filing.
What did Your Advocates Ltd., LLP sell last quarter?
In Q2 2026, Your Advocates Ltd., LLP cut from its top 50 Monopar Therapeutics Inc (MNPR), cut from its top 50 Ishares Tr (IVE), cut from its top 50 Ishares Tr (IVW), cut from its top 50 Technipfmc PLC (FTI), cut from its top 50 Spdr Series Trust (SPTI), Pimco ETF Tr (BOND) (-45.4% shares), Marathon Petroleum (MPC) (-32.6% shares) and Tesla Inc (TSLA) (-12.5% shares), compared with its Q1 2026 filing.
How has Your Advocates Ltd., LLP's portfolio performed?
A portfolio copying Your Advocates Ltd., LLP's 20 largest 13F holdings each quarter, from the day each filing was public, returned +14.8% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +20.0% against +20.1%. Over 5 years: +6.8% a year against +11.6%.
When is Your Advocates Ltd., LLP's next 13F filing due?
13F filings are due 45 days after each quarter ends. Your Advocates Ltd., LLP's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Your Advocates Ltd., LLP manage?
Your Advocates Ltd., LLP reported $448.1M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $349.9M.